Ocugen Investoren 2022 WKN: A2PSZH ISIN: US67577C1053 Kürzel: OCGN Forum: Aktien User: Ad_Astra

Der Kurs spiegelt es gerade. Hoffe, dass wir nicht rasiert werden unter 40 Cent , sonst erleben wir noch Einstiegskurse von 2020 0,24 . Und da ist OC nicht mehr weit weg. Es ist wirklich sehr traurig dieser komplett Absturz.

Das meinte ich

Kann dir nicht sagen woran es liegt. Aber hab immer mehr und mehr schlechtes Gefühl 🤷🏼‍♂️

hat mehr Einsicht der Finanzen in dem halben Jahr gewonnen und hat den Fisch gemacht oder ist mit Shankar nicht klar gekommen. Oder…?

Richtig, der ist erst 7 Monate da 🤦🏼‍♂️

Vu kam doch erst in 02 2023.

MALVERN, Pa., March 06, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced the appointment of Quan A. Vu to Chief Financial Officer & Chief Business Officer. “Quan has quickly become a tremendous asset for Ocugen and his comprehensive healthcare and financial expertise is providing valuable insight toward reaching our corporate goals,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “With Quan now overseeing both finance and business development, there will be a fully integrated approach to financial strategy—pursuing new partnerships and engaging with the investment community.” Mr. Vu joined Ocugen on February 1, 2023, and has been working closely across multiple, key corporate functions—understanding short- and long-term business and financial needs of the Company along with the potential of its differentiated scientific platforms. With his additional appointment as Chief Financial Officer, and aside from his management and oversight of the finance and accounting functions, Mr. Vu will partner closely with Dr. Musunuri to enhance the Company’s forward-looking, value-additive financial initiatives by leveraging the Company’s anticipated clinical milestone achievements to bolster fundamental shareholder composition, expand interactions with the investor community, and ensure reputable capital markets and equity research support

Vu ist nicht mehr CFO und Shankar hat diese Posten interim übernommen

https://last10k.com/sec-filings/OCGN/0001104659-23-091939.htm

Am liebsten 3 und mehr.

Was kommt zu erst?

Guten Morgen zusammen 😃. Wie ist die Lage bei Ocugen? Was können wir zuerst erwarten eure Meinung nach?

https://twitter.com/ocugen/status/1689323182459691033?s=46&t=EXaC4wXwS71BbmJHwvwGrQ